Distinguished in WT1-Related Wilms Tumor Syndromes

Dr. Clyde Jones

Hematology Oncology | Hematology | Oncology
80 Humphreys Center Dr Ste 330, 
Memphis, TN 
Clinical Trials:Currently Recruiting for 1 Trial
Offers Telehealth

Distinguished in WT1-Related Wilms Tumor Syndromes
80 Humphreys Center Dr Ste 330, 
Memphis, TN 
OverviewInsuranceLocationsClinical ResearchSimilar Doctors

Overview

Clyde Jones is a Hematologist Oncology specialist and a Hematologist in Memphis, Tennessee. Dr. Jones is rated as a Distinguished provider by MediFind in the treatment of WT1-Related Wilms Tumor Syndromes. His top areas of expertise are Paget Disease of the Breast, Protein S Deficiency, Hereditary Resistance to Anti-Vitamin K, Protein C Deficiency, and Bone Marrow Aspiration.

His clinical research consists of co-authoring 3 peer reviewed articles and participating in 5 clinical trials. MediFind looks at clinical research from the past 15 years.

Specialties
Hematology Oncology
Hematology
Oncology
Licenses
Internal Medicine in MS
Languages Spoken
English
Gender
Male

Insurance

Accepted insurance can change. Please verify directly with the provider.

Find your insurance
Find your insuranceClose

Accepted insurance plans:

Blue Cross Blue Shield
  • EPO
  • HMO
  • POS
  • PPO
Cigna
  • EPO
  • HMO
  • PPO
Health Care Services Corporation
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • MEDICARE SNP
  • OTHER COMMERCIAL
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
  • PPO
Highmark
  • EPO
  • HMO
  • PPO
HMO Partners
  • POS
Humana
  • HMO
  • INDEMNITY
  • POS
  • PPO
Louisiana Healthcare Connections
  • HMO
  • MANAGED MEDICAID PLAN
UnitedHealthcare
  • EPO
  • HMO
  • POS
  • PPO
Wellcare
  • EPO
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • MEDICARE SNP
  • MEDICARE-MEDICAID PLAN
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
View 4 Less Insurance Carriers -

Locations

80 Humphreys Center Dr Ste 330, Memphis, TN 38120
Call: 901-752-6131
Other Locations
391 Southcrest Cir Ste 101, Southaven, MS 38671
Call: 662-349-0755

Additional Areas of Focus

Dr. Jones has provided the following conditions as areas of focus. Please note that we may not have enough data to validate their experience in some of these conditions.

Neurofibromatosis Type 1 (NF1)

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.


5 Clinical Trials

A Randomized Phase 3 Study of the Efficacy and Safety of Glufosfamide Compared With Fluorouracil (5-FU) in Patients With Metastatic Pancreatic Adenocarcinoma Previously Treated With Gemcitabine
A Randomized Phase 3 Study of the Efficacy and Safety of Glufosfamide Compared With Fluorouracil (5-FU) in Patients With Metastatic Pancreatic Adenocarcinoma Previously Treated With Gemcitabine
Enrollment Status: Recruiting
Publish Date: December 31, 2024
Intervention Type: Drug
Study Drugs: Glufosfamide, Fluorouracil
Study Phase: Phase 3
MONARCH 2: A Randomized, Double-Blind, Placebo-Controlled, Phase 3 Study of Fulvestrant With or Without Abemaciclib, a CDK4/6 Inhibitor, for Women With Hormone Receptor Positive, HER2 Negative Locally Advanced or Metastatic Breast Cancer
MONARCH 2: A Randomized, Double-Blind, Placebo-Controlled, Phase 3 Study of Fulvestrant With or Without Abemaciclib, a CDK4/6 Inhibitor, for Women With Hormone Receptor Positive, HER2 Negative Locally Advanced or Metastatic Breast Cancer
Enrollment Status: Active_not_recruiting
Publish Date: April 20, 2025
Intervention Type: Drug
Study Drugs: Abemaciclib, Fulvestrant
Study Phase: Phase 3
Pattern of Use and Safety/Effectiveness of Nivolumab in Routine Oncology Practice
Pattern of Use and Safety/Effectiveness of Nivolumab in Routine Oncology Practice
Enrollment Status: Completed
Publish Date: June 03, 2024
A Phase 2, Open-Label Study Evaluating the Efficacy, Safety, Tolerability, and Pharmacodynamics of GS-9973 in Subjects With Relapsed or Refractory Hematologic Malignancies
A Phase 2, Open-Label Study Evaluating the Efficacy, Safety, Tolerability, and Pharmacodynamics of GS-9973 in Subjects With Relapsed or Refractory Hematologic Malignancies
Enrollment Status: Terminated
Publish Date: November 19, 2020
Intervention Type: Drug
Study Phase: Phase 2
An Open-label, Multi-center, Expanded Treatment Protocol (ETP) of Oral LDK378 in Adult Patients With Non-small Cell Lung Cancer (NSCLC) Characterized by ALK Positivity
An Open-label, Multi-center, Expanded Treatment Protocol (ETP) of Oral LDK378 in Adult Patients With Non-small Cell Lung Cancer (NSCLC) Characterized by ALK Positivity
Enrollment Status: No_longer_available
Publish Date: November 03, 2020
Intervention Type: Drug
View 4 Less Clinical Trials

3 Total Publications

Treatment of Malignant Pleural Mesothelioma: American Society of Clinical Oncology Clinical Practice Guideline.
Treatment of Malignant Pleural Mesothelioma: American Society of Clinical Oncology Clinical Practice Guideline.
Journal: Journal of clinical oncology : official journal of the American Society of Clinical Oncology
Published: January 19, 2018
View All 3 Publications
Similar Doctors
Distinguished in WT1-Related Wilms Tumor Syndromes
Dr. Daniel Vaena
Hematology | Oncology
Distinguished in WT1-Related Wilms Tumor Syndromes
Dr. Daniel Vaena
Hematology | Oncology

The West Clinic, PLLC

7668 Airways Blvd, 
Southaven, MS 
 (12.9 miles away)
662-349-9556
Languages Spoken:
English
See accepted insurances
Offers Telehealth

Daniel Vaena is a Hematologist and an Oncologist in Southaven, Mississippi. Dr. Vaena is rated as a Distinguished provider by MediFind in the treatment of WT1-Related Wilms Tumor Syndromes. His top areas of expertise are Renal Cell Carcinoma (RCC), Urothelial Cancer, WT1-Related Wilms Tumor Syndromes, and Clear Cell Sarcoma.

Distinguished in WT1-Related Wilms Tumor Syndromes
Dr. David Portnoy
Hematology | Oncology
Distinguished in WT1-Related Wilms Tumor Syndromes
Dr. David Portnoy
Hematology | Oncology

The West Clinic, PLLC

7945 Wolf River Blvd, 
Germantown, TN 
 (3.2 miles away)
901-683-0055
Languages Spoken:
English
See accepted insurances
Offers Telehealth

David Portnoy is a Hematologist and an Oncologist in Germantown, Tennessee. Dr. Portnoy is rated as a Distinguished provider by MediFind in the treatment of WT1-Related Wilms Tumor Syndromes. His top areas of expertise are Liposarcoma, Adult Soft Tissue Sarcoma, Rhabdomyosarcoma Embryonal, Retroperitoneal Liposarcoma, and Pancreaticoduodenectomy.

Distinguished in WT1-Related Wilms Tumor Syndromes
Dr. Michael G. Martin
Hematology Oncology | Hematology | Oncology
Distinguished in WT1-Related Wilms Tumor Syndromes
Dr. Michael G. Martin
Hematology Oncology | Hematology | Oncology

The West Clinic, PLLC

7945 Wolf River Blvd, 
Germantown, TN 
 (3.2 miles away)
901-683-0055
Languages Spoken:
English
See accepted insurances
Accepting New Patients
Offers Telehealth

Michael Martin is a Hematologist Oncology specialist and a Hematologist in Germantown, Tennessee. Dr. Martin is rated as a Distinguished provider by MediFind in the treatment of WT1-Related Wilms Tumor Syndromes. His top areas of expertise are Colorectal Cancer, Familial Colorectal Cancer, Lynch Syndrome, Childhood Iron Deficiency Anemia, and Bone Marrow Aspiration. Dr. Martin is currently accepting new patients.

VIEW MORE WT1-RELATED WILMS TUMOR SYNDROMES DOCTORS

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Dr. Jones's expertise for a condition
ConditionClose
    • Distinguished
    • Angiosarcoma
      Dr. Jones is
      Distinguished
      . Learn about Angiosarcoma.
      See more Angiosarcoma experts
    • Chromophobe Renal Cell Carcinoma
      Dr. Jones is
      Distinguished
      . Learn about Chromophobe Renal Cell Carcinoma.
      See more Chromophobe Renal Cell Carcinoma experts
    • Chronic Lymphocytic Leukemia (CLL)
      Dr. Jones is
      Distinguished
      . Learn about Chronic Lymphocytic Leukemia (CLL).
      See more Chronic Lymphocytic Leukemia (CLL) experts
    • Colorectal Cancer
      Dr. Jones is
      Distinguished
      . Learn about Colorectal Cancer.
      See more Colorectal Cancer experts
    • Congenital Antithrombin 3 Deficiency
      Dr. Jones is
      Distinguished
      . Learn about Congenital Antithrombin 3 Deficiency.
      See more Congenital Antithrombin 3 Deficiency experts
    • Familial Colorectal Cancer
      Dr. Jones is
      Distinguished
      . Learn about Familial Colorectal Cancer.
      See more Familial Colorectal Cancer experts
    View All 18 Distinguished Conditions
    • Advanced
    • 2q37 Deletion Syndrome
      Dr. Jones is
      Advanced
      . Learn about 2q37 Deletion Syndrome.
      See more 2q37 Deletion Syndrome experts
    • 47 XYY Syndrome
      Dr. Jones is
      Advanced
      . Learn about 47 XYY Syndrome.
      See more 47 XYY Syndrome experts
    • Aase Syndrome
      Dr. Jones is
      Advanced
      . Learn about Aase Syndrome.
      See more Aase Syndrome experts
    • Abruzzo-Erickson Syndrome
      Dr. Jones is
      Advanced
      . Learn about Abruzzo-Erickson Syndrome.
      See more Abruzzo-Erickson Syndrome experts
    • Acrodermatitis Enteropathica
      Dr. Jones is
      Advanced
      . Learn about Acrodermatitis Enteropathica.
      See more Acrodermatitis Enteropathica experts
    • Acrorenal Mandibular Syndrome
      Dr. Jones is
      Advanced
      . Learn about Acrorenal Mandibular Syndrome.
      See more Acrorenal Mandibular Syndrome experts
    View All 124 Advanced Conditions
    • Experienced
    • Acute Lymphoblastic Leukemia (ALL)
      Dr. Jones is
      Experienced
      . Learn about Acute Lymphoblastic Leukemia (ALL).
      See more Acute Lymphoblastic Leukemia (ALL) experts
    • Acute Myeloblastic Leukemia with Maturation
      Dr. Jones is
      Experienced
      . Learn about Acute Myeloblastic Leukemia with Maturation.
      See more Acute Myeloblastic Leukemia with Maturation experts
    • Acute Myeloblastic Leukemia without Maturation
      Dr. Jones is
      Experienced
      . Learn about Acute Myeloblastic Leukemia without Maturation.
      See more Acute Myeloblastic Leukemia without Maturation experts
    • Acute Myeloid Leukemia (AML)
      Dr. Jones is
      Experienced
      . Learn about Acute Myeloid Leukemia (AML).
      See more Acute Myeloid Leukemia (AML) experts
    • Acute Myelomonocytic Leukemia
      Dr. Jones is
      Experienced
      . Learn about Acute Myelomonocytic Leukemia.
      See more Acute Myelomonocytic Leukemia experts
    • Adult Immune Thrombocytopenia
      Dr. Jones is
      Experienced
      . Learn about Adult Immune Thrombocytopenia.
      See more Adult Immune Thrombocytopenia experts
    View All 148 Experienced Conditions
    Want to save this doctor for later?
    Sign Up
    Is this your doctor?
    Find A Second Opinion
    Not sure about your diagnosis?
    Check Your Symptoms
     
     
     
     
    Learn about our expert tiers
    Learn More
    Are you the provider on this profile?
    Claim Profile
    For Patients
    • Our Story
    • How MediFind Works
    • Conditions A-Z
    • Doctor Directory
    • Symptoms Directory
    • Procedures Directory
    • Treatment Directory
    • Drug Directory
    • Infusion Center Finder
    • FAQ
    • Contact Us
    For Providers and Practices
    • Claim Your Profile
    • Newsroom
    Business Solutions
    • Provider
    • Network Solutions
    Additional Resources
    • Consumer Health Data Privacy Policy
    • Privacy Policy
    • Terms of Use
    • Advertising Policy
    • Content Policy
    Subscribe to our newsletter

    Sign up to stay informed about MediFind and get wellness sent your way.

    Close

      By subscribing, I agree to MediFind's Terms of Use, Privacy Policy and Consumer Health Data Privacy Policy, as applicable.

      Bullet PinMediFind
      Follow us on
      This information is not intended as a substitute for informed medical advice. You should work with a licensed professional to diagnose and treat health conditions. We let the data speak for itself, MediFind does not endorse any healthcare providers.
      © 2025 All Rights Reserved